People who experience four weeks on semaglutide with no weight loss often find that the dose increase is what finally triggers meaningful changes
FDA-approved indications require either a BMI of 30+ or BMI of 27+ with comorbidities for weight management, or a type 2 diabetes diagnosis for the diabetes formulations
Walker RJ, Garacci E, Palatnik A, Ozieh MN, Egede LE (2020) The longitudinal influence of social determinants of health on glycemic control in elderly adults with Diabetes
And I think that thats really important because if you do get an immobilizer and you have your leg immobilized, if youre going to come back from that, we need to know that if you have the GLP-1s, does it prevent you from increasing your muscle mass and strength again in the rehab period of time
A few things to verify before billing Medicaid for any injection: State-level NCCI edits may differ from Medicare NCCI edits, so verify which NCCI version applies in your state Some states require prior authorization for GLP-1 agents, biologics, and extended-release injectables even when the federal Medicare standard doesn't Managed Medicaid plans operate under commercial contracts that often have different coverage rules than fee-for-service Medicaid Medicaid prior authorization requirements for injectable drugs are among the most variable in the payer landscape